ClinicalTrials.gg
Enrolling by invitationNCT07944976HEADSPINUpdated Nov 18, 2026

HEAD Position Sensing for the Particle Repositioning Maneuver Technique IN Benign Paroxysmal Positional Vertigo: a Validation and Feasibility Study

An interventional study of HEADSPIN Device and HEADSPIN device in Vertigo Vestibular, Epley Maneuver and Dizziness and Vertigo, sponsored by Cambridge University Hospitals NHS Foundation Trust. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Primary conditionBenign Paroxysmal Positional VertigoRegistry: VertigoReclassifiedWhy we changed it
Registry
Vertigo — the first condition term the registry derived for this study.
ClinicalTrials.gg
Benign Paroxysmal Positional Vertigo
Why
  1. The study's listed conditions name Benign Paroxysmal Positional Vertigo, a narrower term within Vertigo.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Cambridge University Hospitals NHS Foundation Trust · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2026, registered Nov 2026).
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The treatment of benign paroxysmal positional vertigo (BPPV) requires movement of the head through several positions. This is known as the particle repositioning manoeuvre or the Epley manoeuvre. Getting this manoeuvre right helps to dislodge debris from the inner ear that might cause the dizziness. The investigators have developed a head sensing device and particle repositioning manoeuvre application designed to support a healthcare professional to perform these movements and treat the condition.

Here the investigators are aiming to see if, with the help of the investigational device and app, a non-specialist (such as an ENT nurse, or a GP doctor) can perform the particle repositioning manoeuvre as well as an ENT specialist can.

The investigators hope that in the future this would allow patients with BPPV to be treated well by a non-specialist and so reduce the waiting times for this treatment manoeuvre.

The investigators aim to validate and assess the utility of a head position sensing device, and a PRM application (App) that will support healthcare professionals perform the manoeuvre.

Read the detailed description

This study is arranged in 3 parts. The investigators will validate our head sensing monitoring device and PRM application (app) to confirm firstly that the device couples accurately to anatomical landmarks during each stage of the PRM, and secondly that performing the PRM guided by the investigators app does move the head through the correct set of positions to remove debris from the posterior semicircular canal.

The former will be achieved by reviewing head position as recorded by video capture (gold standard) technology vs head position calculated by the investigational device in multiple trials when the device is applied by different investigators in up to 10 different participants. The second validation will be achieved by using a specialized manikin head that contains a 3D printed inner ear that can be visualized with an inbuilt camera. As the manikin is guided through the PRM the investigators will observe the effects of the PRM on debris within the posterior canal.

The second part is a feasibility and usability study. The investigators will demonstrate the device to a population of Ear nose and throat (ENT) nurses, Emergency Department (ED) doctors and General Practitioners (GPs).The investigators will collect response to a questionnaire regarding likelihood they would perform the PRM and assess confidence in performing the PRM with or without access to a supporting device.

Finally, to assess feasibility of use in clinical practice the investigators will recruit 20 patients with BPPV and randomize them into two groups: PRM by specialist practitioner or PRM by non-specialist practioners but guided by the device. The investigators will assess outcomes immediately after the PRM, as well as at 1month post PRM by telephone consultation and use of the dizziness handicap inventory as well as a novel questionnaire the investigators have developed specific for BPPV. The investigators will also give a questionnaire to the practitioners to complete to evaluate the device and application

02

Conditions studied

  • Vertigo Vestibular
  • Epley Maneuver
  • Dizziness and Vertigo
  • Benign Paroxysmal Positional Vertigo (BPPV)

Browse trials for

Keywords

  • BPPV
  • Medical Device
  • Vertigo
  • Epley maneuver
  • dizziness and vertigo
  • HEADSPIN
  • Head Tracking
  • Benign paroxysmal positional vertigo
03

In context

Benign Paroxysmal Positional Vertigo Reclassified

76 studies on the registry are indexed under Benign Paroxysmal Positional Vertigo; 16 are open to participants now.

This study's planned enrollment of 20 is below the median of 75 across 63 interventional studies indexed under Benign Paroxysmal Positional Vertigo.

Browse Benign Paroxysmal Positional Vertigo studies →

Lead sponsor

Cambridge University Hospitals NHS Foundation Trust is the lead sponsor of 172 studies on the registry; 39 are open to participants now.

Compared within Benign Paroxysmal Positional Vertigo, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Vertigo. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Positive Dix-Hallpike test for posterior canalithiasis.
  • Diagnosis of posterior canal BPPV
  • Considered appropriate for PRM by specialist clinician with no medical for the manoeuvre identified (ENT surgeon or vestibular rehabilitation therapist)

Exclusion criteria

Exclusion Criteria:

    • Not considered appropriate to undergo the PRM by specialist clinician. *

      • Negative Dix-Hallpike test
      • History of recent spinal surgery, carotid stenosis, unstable cardiac disease.
      • Previous PRM for treatment of BPPV in the last 2months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Patient with BPPV, given Epley maneuve using device

    Pt attends clinic, confirmed eligible with BPPV and randomized to have the treatment using the HEADSPIN Device

    Device: HEADSPIN Device

  • Placebo comparator
    Patient with BPPV, given Epley maneuve without using device

    Pt attends clinic, confirmed eligible with BPPV and randomized to have the non treatment arm. Wearing the HEADSPIN Device, but the clinician will not be taking any readings or direction from it.

    Device: HEADSPIN device

Interventions

  • DeviceHEADSPIN Device

    HEADSPIN device used with PRM App to direct clinician in standardizing application of Epley maneuver

  • DeviceHEADSPIN device

    Wearing HeadSPIN device only; no readings taken from the device or app. Clinician using clinical knowledge to deliver an effective Epley maneuver to patient.

06

What researchers measure

Primary outcomes

  1. To identify patient improvement using Dizziness Handicap Inventory Questionnaire and Novel HEADSPIN BPPV Symptom Questionnaire taken before and after using the HEADSPIN device

    Confirm validity of the device through data of patients, at the 6 week follow up call assess patients improvement from their initial BPPV symptoms. Assessed by Dizziness Handicap Inventory Scale and Novel HEADSPIN Symptom Questionnaire to identify improvement.

    Time frame: Six weeks post Epley maneuver

Secondary outcomes

  1. Are Epley maneuvers performed by non-specialist staff aided by the HEADSPIN device as good as those performed by specialist ENT staff?

    Compare patients who have had procedures performed by specialist ENT Staff and those who have had it performed with the HEADSPIN device and non specialist ENT Staff. Which patients had the better long term outcome at 12 weeks.

    Time frame: 12 weeks

  2. Does the HEADSPIN device support clinicians perform the particle repositioning manoeuvre (PRM)

    Through a Questionnaire given to clinicians, do the non specialist ENT clinical staff feel supported and more confident in performing the maneuver whilst the patient is wearing the HEADSPIN Device.

    Time frame: 12 weeks

07

Study locations

1 site
  • Cambridge University Hosptials NHS Foundation Trust
    Cambridge, CB2 OQQ, United Kingdom
08

References and documents

Individual participant data

Plan to share: Yes — Only fully anonymized data to be shared at consent of participant as per IRAS instruction and approved by REC

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Sep 2026, 1 month.

Of 39 non-industry interventional studies with no phase under Benign Paroxysmal Positional Vertigo, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 26. This study's 1 month is below that.

Counting every sponsor, half of 40 studies reached it within 16 months; a quarter within 8 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 18, 2026
StartActual
Jul 23, 2026
Primary completionActual
Sep 15, 2026
CompletionEst.
Jan 1, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944976
Collaborators
British Medical Association, University of Cambridge
Responsible party
Sophie McKenny (R+D Clinical Lead, Cambridge University Hospitals NHS Foundation Trust) — Principal investigator
First posted
Nov 18, 2026
Start date
Jul 23, 2026
Primary completion
Sep 15, 2026
Completion
Jan 1, 2027 (estimated)
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion